Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022
25 avr. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022,...
Throne Biotechnologies Wins '5 Best BioTech Companies To Watch' Award From The Silicon Review
28 mars 2022 09h00 HE
|
Throne Biotechnologies Inc
PARAMUS, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies (Throne), one of the global-leading biotech companies aiming to find a cure for type 1 diabetes and other autoimmune...
Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives
22 mars 2022 16h06 HE
|
Exagen Inc.
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests will soon surpass 90 million lives as...
Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results
22 mars 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022
08 mars 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
Fifth Update of ACR COVID-19 Vaccine Guidance Supports Fourth Doses for High-Risk Rheumatic Disease Patients
02 févr. 2022 10h49 HE
|
American College of Rheumatology
Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and...
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection
09 janv. 2022 12h00 HE
|
Exagen Inc.
SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a...
Autoimmune Disease Therapeutics Market Report Up to 2031: Visiongain Research Inc
23 déc. 2021 09h00 HE
|
Visiongain Ltd
Visiongain has published a new report on Autoimmune Disease Therapeutics Market Report to 2031. Market is segmented By Indication (Rheumatic Disease, Multiple Sclerosis, Diabetes, Inflammatory Bowel...
Animal Autoimmune Disease Diagnostics Market Report Up to 2031: By Visiongain Research Inc
16 nov. 2021 06h13 HE
|
Visiongain Ltd
Visiongain has published a new report on Animal Autoimmune Disease Diagnostics Market Report to 2031: Forecasts By Test Type (Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, DNA...
Clinical Trial Market Size & Share 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
09 nov. 2021 06h00 HE
|
Graphical Research
Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global clinical trial market size is estimated to rise exponentially during the forecast period, as the need for advanced vaccines and drugs to...